• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对罗讷-阿尔卑斯地区综合且前瞻性肉瘤患者系列中初始诊断与中心病理复查之间一致性的流行病学评估。

Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.

机构信息

Centre Léon Bérard, Lyon, France.

出版信息

BMC Cancer. 2010 Apr 19;10:150. doi: 10.1186/1471-2407-10-150.

DOI:10.1186/1471-2407-10-150
PMID:20403160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2873387/
Abstract

BACKGROUND

Sarcomas are rare malignant tumors. Accurate initial histological diagnosis is essential for adequate management. We prospectively assessed the medical management of all patients diagnosed with sarcoma in a European region over a one-year period to identify the quantity of first diagnosis compared to central expert review (CER).

METHODS

Histological data of all patients diagnosed with sarcoma in Rhone-Alpes between March 2005 and Feb 2006 were collected. Primary diagnoses were systematically compared with second opinion from regional and national experts.

RESULTS

Of 448 patients included, 366 (82%) matched the inclusion criteria and were analyzed. Of these, 199 (54%) had full concordance between primary diagnosis and second opinion (the first pathologist and the expert reached identical conclusions), 97 (27%) had partial concordance (identical diagnosis of conjonctive tumor but different grade or subtype), and 70 (19%) had complete discordance (different histological type or invalidation of the diagnosis of sarcoma). The major discrepancies were related to histological grade (n = 68, 19%), histological type (n = 39, 11%), subtype (n = 17, 5%), and grade plus subtype or grade plus histological type (n = 43, 12%).

CONCLUSIONS

Over 45% of first histological diagnoses were modified at second reading, possibly resulting in different treatment decisions. Systematic second expert opinion improves the quality of diagnosis and possibly the management of patients.

摘要

背景

肉瘤是罕见的恶性肿瘤。准确的初始组织学诊断对于充分的治疗至关重要。我们前瞻性评估了在一个欧洲地区一年内所有诊断为肉瘤的患者的医学管理,以确定首次诊断的数量与中心专家审查(CER)相比。

方法

收集了 2005 年 3 月至 2006 年 2 月在罗纳-阿尔卑斯地区诊断为肉瘤的所有患者的组织学数据。对首次诊断与区域和国家专家的第二意见进行了系统比较。

结果

448 例患者中,366 例(82%)符合纳入标准并进行了分析。其中,199 例(54%)首次诊断与第二意见完全一致(第一病理学家和专家得出了相同的结论),97 例(27%)部分一致(诊断为结蹄组织肿瘤,但分级或亚型不同),70 例(19%)完全不一致(组织学类型不同或肉瘤诊断无效)。主要差异与组织学分级(n=68,19%)、组织学类型(n=39,11%)、亚型(n=17,5%)以及分级+亚型或分级+组织学类型(n=43,12%)有关。

结论

超过 45%的首次组织学诊断在第二次阅读时被修改,可能导致不同的治疗决策。系统的第二次专家意见可提高诊断质量,并可能改善患者的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bc/2873387/a7da89e306ba/1471-2407-10-150-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bc/2873387/a7da89e306ba/1471-2407-10-150-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64bc/2873387/a7da89e306ba/1471-2407-10-150-1.jpg

相似文献

1
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.对罗讷-阿尔卑斯地区综合且前瞻性肉瘤患者系列中初始诊断与中心病理复查之间一致性的流行病学评估。
BMC Cancer. 2010 Apr 19;10:150. doi: 10.1186/1471-2407-10-150.
2
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions.肉瘤:在三个欧洲地区的基于人群的研究中,初始诊断与集中专家审查之间的一致性。
Ann Oncol. 2012 Sep;23(9):2442-2449. doi: 10.1093/annonc/mdr610. Epub 2012 Feb 13.
3
[Histopathological diagnostic concordance in bone and soft tissue sarcomas between two comprehensive cancer centers from eastern and western Europe: a collaborative experience].[欧洲东部和西部两个综合癌症中心之间骨与软组织肉瘤的组织病理学诊断一致性:一项合作经验]
Ann Pathol. 2015 Jan;35(1):32-40. doi: 10.1016/j.annpat.2014.11.002. Epub 2014 Dec 23.
4
A European project on incidence, treatment, and outcome of sarcoma.一个关于肉瘤发病率、治疗和结果的欧洲项目。
BMC Public Health. 2010 Apr 12;10:188. doi: 10.1186/1471-2458-10-188.
5
Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing.一项前瞻性的流行病学研究,对中央病理审查和分子检测,肉瘤的组织类型和分子亚型的发生率。
PLoS One. 2011;6(8):e20294. doi: 10.1371/journal.pone.0020294. Epub 2011 Aug 3.
6
Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region.肉瘤患者管理方面的地区不平等及对临床指南的遵循情况:罗讷-阿尔卑斯地区基于人群的详尽队列分析
Int J Clin Oncol. 2014 Aug;19(4):744-52. doi: 10.1007/s10147-013-0601-2. Epub 2013 Aug 10.
7
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.利用专家病理审查网络,四年间全国范围内的中间恶性肉瘤和结缔组织肿瘤的发病率。
PLoS One. 2021 Feb 25;16(2):e0246958. doi: 10.1371/journal.pone.0246958. eCollection 2021.
8
Discordance Between the Initial Diagnosis of Sarcomas and Subsequent Histopathological Revision and Molecular Analyses in a Sarcoma Reference Center in Brazil.巴西一家肉瘤参考中心肉瘤的初始诊断与后续组织病理学修正及分子分析之间的不一致性。
JCO Glob Oncol. 2024 Jul;10:e2300431. doi: 10.1200/GO.23.00431.
9
Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG).国家罕见妇科癌症网络(TMRG)中的二次审查揭示的潜在组织学差异。
Gynecol Oncol. 2022 Jun;165(3):637-641. doi: 10.1016/j.ygyno.2022.03.019. Epub 2022 Apr 4.
10
[Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region].[肉瘤的发病率、流行病学及分子生物学。罗纳-阿尔卑斯地区EMS研究的初步结果]
Bull Cancer. 2010 Jun;97(6):629-41. doi: 10.1684/bdc.2010.1117.

引用本文的文献

1
Transcriptomic-Based Classification Identifies Prognostic Subtypes and Therapeutic Strategies in Soft Tissue Sarcomas.基于转录组学的分类可识别软组织肉瘤的预后亚型和治疗策略。
Cancers (Basel). 2025 Aug 30;17(17):2861. doi: 10.3390/cancers17172861.
2
ASO Practice Guidelines Series: Soft Tissue Sarcoma of the Extremities and Superficial Trunk.美国骨科学会(ASO)实践指南系列:四肢及浅表躯干软组织肉瘤
Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18223-7.
3
Genetic and Molecular Heterogeneity of Synovial Sarcoma and Associated Challenges in Therapy.

本文引用的文献

1
Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification.世界卫生组织分类时代的淋巴瘤专家二次病理审查。
Ann Oncol. 2012 Jan;23(1):159-166. doi: 10.1093/annonc/mdr029. Epub 2011 Mar 17.
2
Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up.软组织肉瘤:ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii89-93. doi: 10.1093/annonc/mdn101.
3
Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhône-Alpes region in France (ARCERRA).
滑膜肉瘤的遗传和分子异质性及治疗相关挑战。
Cells. 2024 Oct 14;13(20):1695. doi: 10.3390/cells13201695.
4
Successful Perioperative and Surgical Treatment of a Rare Case of Extra-Gastrointestinal Stromal Tumor Arising in the Prostate Gland.前列腺罕见的胃肠道外间质瘤的成功围手术期及手术治疗
Case Rep Oncol. 2019 Feb 20;12(1):183-191. doi: 10.1159/000496686. eCollection 2019 Jan-Apr.
5
The Impact of Expert Pathology Review and Molecular Diagnostics on the Management of Sarcoma Patients: A Prospective Study of the Hellenic Group of Sarcomas and Rare Cancers.专家病理审查和分子诊断对肉瘤患者管理的影响:希腊肉瘤和罕见癌症研究组的前瞻性研究
Cancers (Basel). 2024 Jun 24;16(13):2314. doi: 10.3390/cancers16132314.
6
"Textbook outcome(s)" in colorectal surgery: a systematic review and meta-analysis.结直肠外科的“教科书结局”:系统评价和荟萃分析。
Ir J Med Sci. 2024 Oct;193(5):2187-2194. doi: 10.1007/s11845-024-03747-w. Epub 2024 Jul 10.
7
Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center.骨与软组织肿瘤转诊至肉瘤中心的组织学诊断差异及其临床影响。
Cancer Sci. 2024 Aug;115(8):2831-2838. doi: 10.1111/cas.16211. Epub 2024 May 19.
8
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.罕见成人实体癌患者的管理:欧洲参考网络(ERN)EURACAN的目标与评估
Lancet Reg Health Eur. 2024 Feb 16;39:100861. doi: 10.1016/j.lanepe.2024.100861. eCollection 2024 Apr.
9
Soft Tissue Sarcomas with Chromosomal Alterations in the 12q13-15 Region: Differential Diagnosis and Therapeutic Implications.12q13 - 15区域存在染色体改变的软组织肉瘤:鉴别诊断及治疗意义
Cancers (Basel). 2024 Jan 19;16(2):432. doi: 10.3390/cancers16020432.
10
Challenges and opportunities for sarcoma care and research in Latin America: a position paper from the LACOG sarcoma group.拉丁美洲肉瘤护理与研究的挑战与机遇:来自拉丁美洲骨肉瘤协作组的立场文件
Lancet Reg Health Am. 2024 Jan 4;30:100671. doi: 10.1016/j.lana.2023.100671. eCollection 2024 Feb.
法国罗纳-阿尔卑斯地区儿童癌症登记处(ARCERRA)纳入患者的随访:儿童癌症和白血病治疗相关死亡(TRD)随时间的趋势
Pediatr Blood Cancer. 2008 Jun;50(6):1213-20. doi: 10.1002/pbc.21506.
4
The value of expert second opinion in diagnosis of soft tissue sarcomas.专家二次诊断意见在软组织肉瘤诊断中的价值。
J Surg Oncol. 2008 Jan 1;97(1):40-3. doi: 10.1002/jso.20897.
5
[Childhood cancer incidence and survival rates in the Rhône-Alpes regional paediatric registry 1987-1999].[1987 - 1999年罗纳-阿尔卑斯地区儿科登记处儿童癌症发病率和生存率]
Arch Pediatr. 2006 Feb;13(2):121-9. doi: 10.1016/j.arcped.2005.10.022. Epub 2006 Jan 11.
6
Soft-tissue sarcomas in adults.成人软组织肉瘤
N Engl J Med. 2005 Aug 18;353(7):701-11. doi: 10.1056/NEJMra041866.
7
[Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment].[软组织肉瘤的病理评估用于诊断、预后和治疗]
Gan To Kagaku Ryoho. 2004 Sep;31(9):1340-5.
8
Errors in diagnosis and margin determination of soft-tissue sarcomas initially treated at non-tertiary centers.在非三级中心首次接受治疗的软组织肉瘤的诊断和切缘确定错误。
Orthopedics. 2004 Feb;27(2):209-12. doi: 10.3928/0147-7447-20040201-14.
9
Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas.软组织肉瘤的临床实践指南遵循情况、多学科管理及治疗结果
Ann Oncol. 2004 Feb;15(2):307-15. doi: 10.1093/annonc/mdh058.
10
Immunohistochemistry in the diagnosis of soft tissue tumours.免疫组织化学在软组织肿瘤诊断中的应用
Histopathology. 2003 Jul;43(1):1-16. doi: 10.1046/j.1365-2559.2003.01639.x.